Idea principal
In 181 chemotherapy-treated breast cancer patients with cognitive problems, 6 months of exercise did not improve the primary memory outcome, but did improve fitness (VO2peak +1.4 ml/min/kg), self-reported cognition, fatigue, quality of life and depression. Tested cognition improved only in a hypothesis-driven subgroup of highly fatigued patients.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Up to 60% of breast cancer patients treated with chemotherapy face cognitive problems that affect daily life and quality of life. The authors tested whether exercise training improves cognition 2 to 4 years after diagnosis.
Población y método
Randomized controlled trial (PAM study; Netherlands Trial Registry NL5924). 181 chemotherapy-exposed breast cancer patients with both self-reported cognitive problems and lower-than-expected performance on neuropsychological tests were randomized to exercise (n = 91) or control (n = 90). The 6-month intervention was supervised aerobic and strength training (2 h/week) plus Nordic or power walking (2 h/week). The primary outcome was memory (Hopkins Verbal Learning Test-Revised, HVLT-R), analysed with a Fisher exact test for clinically relevant improvement of 5 words or more. Secondary outcomes were online neuropsychological tests (Amsterdam Cognition Scan), self-reported cognition (MDASI-MM), VO2peak, fatigue, quality of life, depression and anxiety, analysed with multiple regression adjusted for baseline and stratification factors.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1No difference favouring the exercise group was seen on the primary outcome, HVLT-R memory.
- 2About two-thirds of patients attended 80% or more of sessions, and fitness improved versus control (VO2peak B 1.4 ml/min/kg, 95% CI 0.6 to 2.2).
- 3Self-reported cognitive functioning improved (MDASI-MM severity B-0.7, 95% CI - 1.2 to - 0.1), as did fatigue, quality of life and depression.
- 4In a hypothesis-driven analysis of highly fatigued patients, exercise improved tested cognition: Amsterdam Cognition Scan reaction time (B-26.8, 95% CI - 52.9 to - 0.6) and wordlist learning (B4.4, 95% CI 0.5 to 8.3).
Límites e incertidumbre
- 1The primary memory outcome showed no benefit, so improvements in secondary outcomes should be treated as exploratory.
- 2The positive effects on tested cognition came from a subgroup of highly fatigued patients, and the lower confidence limits are close to zero, so the finding is fragile.
- 3Participants knew they were exercising, which can raise self-reported outcomes such as cognition and fatigue; the abstract does not describe blinding.
- 4Only patients with both self-reported problems and low test performance were included, and the abstract does not report results beyond 6 months. This reading is based on the abstract only.
Relevancia práctica
Exercise made these patients fitter and helped them feel better in fatigue, mood and everyday thinking, even though a formal memory test did not improve. That is a reasonable reason to discuss structured exercise with your oncology team, but not to expect it to fix test-measured memory. Any programme after cancer treatment should be agreed with your clinician.
Tus datos
Heart rate during training and VO2max estimates from a watch can show whether fitness is trending upward, though watch estimates are not the laboratory VO2peak used here. Track weekly session minutes and subjective fatigue and mood in a simple log, using the same device and conditions.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Up to 60% of breast cancer patients treated with chemotherapy is confronted with cognitive problems, which can have a significant impact on daily activities and quality of life (QoL). We investigated whether exercise training improves cognition in chemotherapy-exposed breast cancer patients 2-4 years after diagnosis.
Methods
Chemotherapy-exposed breast cancer patients, with both self-reported cognitive problems and lower than expected performance on neuropsychological tests, were randomized to an exercise or control group. The 6-month exercise intervention consisted of supervised aerobic and strength training (2 h/week), and Nordic/power walking (2 h/week). Our primary outcome was memory functioning (Hopkins Verbal Learning Test-Revised; HVLT-R). Secondary outcomes included online neuropsychological tests (Amsterdam Cognition Scan; ACS), self-reported cognition (MD Anderson Symptom Inventory for multiple myeloma; MDASI-MM), physical fitness (relative maximum oxygen uptake; VO_(2peak)), fatigue (Multidimensional Fatigue Inventory), QoL (European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; EORTC QLQ C-30), depression (Patient Health Questionnaire-9, Hospital Anxiety and Depression Scale; HADS), and anxiety (HADS). HVLT-R total recall was analyzed with a Fisher exact test for clinically relevant improvement (≥ 5 words). Other outcomes were analyzed using multiple regression analyses adjusted for baseline and stratification factors.
Results
We randomized 181 patients to the exercise (n = 91) or control group (n = 90). Two-third of the patients attended ≥ 80% of the exercise sessions, and physical fitness significantly improved compared to control patients (B VO_(2peak) 1.4 ml/min/kg, 95%CI:0.6;2.2). No difference in favor of the intervention group was seen on the primary outcome. Significant beneficial intervention effects were found for self-reported cognitive functioning [MDASI-MM severity (B-0.7, 95% CI - 1.2; - 0.1)], fatigue, QoL, and depression. A hypothesis-driven analysis in highly fatigued patients showed positive exercise effects on tested cognitive functioning [ACS Reaction Time (B-26.8, 95% CI - 52.9; - 0.6) and ACS Wordlist Learning (B4.4, 95% CI 0.5; 8.3)].
Conclusions
A 6-month exercise intervention improved self-reported cognitive functioning, physical fitness, fatigue, QoL, and depression in chemotherapy-exposed breast cancer patients with cognitive problems. Tested cognitive functioning was not affected. However, subgroup analysis indicated a positive effect of exercise on tested cognitive functioning in highly fatigued patients. Trial Registration Netherlands Trial Registry: Trial NL5924 (NTR6104). Registered 24 October 2016, https://www.trialregister.nl/trial/5924 .
Fuentes y atribución
Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study).
Koevoets EW, Schagen SB, de Ruiter MB, Geerlings MI, Witlox L, van der Wall E, Stuiver MM, Sonke GS, Velthuis MJ, Jobsen JJ, Menke-Pluijmers MBE, Göker E, van der Pol CC, Bos MEMM, Tick LW, van Holsteijn NA, van der Palen J, May AM, Monninkhof EM, PAM study group.
Breast cancer research : BCR · 2022-05-26
DOI: 10.1186/s13058-022-01530-2 ↗PubMed · 35619188 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise gave small-to-moderate cognitive gains across 133 reviews of trials
An umbrella review of 133 systematic reviews (2724 trials, 258,279 participants) found that exercise improved general cognition (SMD 0.42, 95% CI 0.37 to 0.47), memory (0.26) and executive function (0.24), with the largest memory gains in children and adolescents and the largest executive function gains in people with ADHD. Most of the reviews (94) were rated critically low in quality and the effects were smaller in the best-rated ones (0.23 for general cognition), and the outcomes were test scores, not dementia.
British Journal of Sports Medicine
More daily steps linked to fewer depressive symptoms across 33 studies of adults
Pooling 33 observational studies of 96,173 adults, higher daily step counts went with fewer depressive symptoms, and in the two prospective cohorts that could be pooled, 7000 or more steps a day went with a lower risk of depression than fewer (RR 0.69, 95% CI 0.62-0.77). Most studies were cross-sectional, so low mood may be reducing steps as much as steps affect mood, and the authors say the prediction intervals call for caution.
JAMA Network Open
Exercise eased depression in 218 trials, but confidence in the evidence is low
In a network meta-analysis of 218 trials with 14,170 people who met criteria for major depression, walking or jogging, yoga, strength training, mixed aerobic exercise and tai chi or qigong each gave moderate reductions in depression compared with active controls (walking or jogging: Hedges' g −0.62, 95% credible interval −0.80 to −0.45). Confidence in the evidence was low for walking or jogging and very low for the other treatments, mainly because only one study met the low-risk-of-bias criteria.
BMJ
Physical activity eased depression and anxiety across 97 reviews of trials
Across 97 systematic reviews that pooled 1039 randomized trials with 128,119 participants, physical activity had medium effects on depression (median effect size −0.43) and anxiety (−0.42) compared with usual care, and higher-intensity activity went with larger gains. Most of those reviews (77) were rated critically low in quality, and the evidence mainly concerns mild-to-moderate symptoms.
British Journal of Sports Medicine

